Worst Performing Stocks for Tax Loss Selling – Wolfe

Seeking AlphaDec 16 14:59 ET

Catalyst Watch: FOMC Meeting, Govt. Funding Drama, Earnings for Micron, Nike, and FedEx

Seeking AlphaDec 13 15:00 ET

Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com

BusinesswireDec 11 12:41 ET

How Much Upside Is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91%

Zacks Dec 11 09:05 ET

Oppenheimer Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $75

Moomoo NewsDec 10 08:34 ET · Ratings

Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound?

Yahoo FinanceDec 6 11:31 ET